Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06515366

MAP( Mean Arterial Pressure) and Mortality Relation in Patients With Heart Failure

Aim of this observational study is to evaluate the relationship between mean arterial pressure (MAP) and mortality in patients presenting to the emergency department with acute heart failure, focusing on emergency department monitoring and subgroup presentations. Our goal is to determine the impact of subgroup characteristics on mortality among patients presenting with heart failure in the emergency department, and to assess the predictive value and significance of MAP in predicting mortality.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Etlik City Hospital

Ankara, Yenimahalle, 06170, Turkey (Türkiye)

Location status: Recruiting

Location contact

bedriye muge sonmez, ass.prof.

SUB_INVESTIGATOR

elif hamzacebioglu kayisoglu, specalist

CONTACT

[email protected]

+905453300679

elif hamzacebioglu kayisoglu, specialist

SUB_INVESTIGATOR

faruk meric, resident

SUB_INVESTIGATOR

gulsen akcay, ass. prof

PRINCIPAL_INVESTIGATOR

gulsen akcay, ass. prof.

CONTACT

[email protected]

+905052874949

murat özdemir, specialist

SUB_INVESTIGATOR

About this study

After obtaining ethical approval, the study will commence within 2 weeks and continue for 1 year. Based on clinical statistics or general literature data, and considering sample size calculations, a total of 280 patients across 4 groups have been determined.

Inclusion criteria

Age 18 and above Patients presenting with symptoms of heart failure

Exclusion criteria

Age under 18 Patients presenting with ST-elevation myocardial infarction Patients with acute kidney failure Pregnant patients Patients with inaccessible data for the parameters under study

Groups based on initial mean arterial pressure (MAP) upon hospital admission will be established as follows: <65 mmHg, 66-80 mmHg, 81-100 mmHg, >100 mmHg. Data including results of emergency department tests and pertinent findings will be recorded for patients in these groups. The 30-day mortality rates of these patients will be statistically evaluated based on their MAP values and the procedures performed during emergency department monitoring.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Age 18 and above Patients presenting with symptoms of heart failure

Exclusion criteria

Age under 18 Patients presenting with ST-elevation myocardial infarction Patients with acute kidney failure Pregnant patients Patients with inaccessible data for the parameters under study

Treatment and study plan

Primary outcomes

  1. mortality

    Time frame: 1 month

    patients having mortaility within 1 month of follow up

Secondary outcomes

  1. re-hospitalization

    Time frame: 1 month

    patients being re-hospitalized within 1 month after discharge from hospital

Study contacts

Contact information is provided by the study sponsor or research team.

elif hamzacebioglu kayisoglu, specialist

CONTACT

[email protected]

+905453300679

gulsen akcay, ass. prof.

CONTACT

[email protected]

+905052874949

Sponsors and collaborators

Lead sponsor

Saglik Bilimleri Universitesi

Other

Collaborators

  • Ankara Etlik City Hospital

Registry information

Official study title

Evaluation of the Relationship Between Mean Arterial Pressure (MAP) and Mortality in Patients With Heart Failure: A Perspective From Emergency Department Monitoring and Hospital Presentation

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Jul 23, 2024
Registry last updated
Jul 23, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.